Abstract
Epidemiologic studies have linked interactions with cats as a risk factor for human leptospirosis, but serosurveys of feline Leptospira spp. infection are scarce in the veterinary literature. The objective of this study was to conduct a serosurvey of Leptospira spp. infection in cats presenting to an eastern Canadian veterinary teaching hospital (VTH). All serum samples collected from cats presented to the VTH were tested by the microscopic agglutination test (MAT) for the Leptospira serovars Canicola, Grippotyphosa, Icterohaemorrhagiae, Bratislava, Pomona, and Autumnalis. Ten of 40 cats [25%; 95% confidence interval (CI): 12.7% to 41.2%] tested had positive antibody titers (≥ 1:100). All 10 cats with positive titers were positive for Bratislava and 2 were also positive for Autumnalis. This high incidence of seropositivity for Leptospira spp. may suggest that the disease could be of more clinical importance than previously recognized.
Résumé
Enquête sérologique sur la leptospirose féline dans un hôpital de référence du Québec. Les études épidémiologiques ont associé les interactions avec les chats comme un facteur de risque pour la leptospirose humaine, mais les enquêtes sérologiques sur l’infection à la leptospirose féline sont rares dans les publications vétérinaires. La présente étude avait pour objectif de réaliser une enquête sérologique de l’infection à Leptospira chez les chats présentés dans un hôpital d’enseignement vétérinaire (HEV) de l’Est du Canada. Tous les échantillons de sérum prélevés auprès des chats présentés à l’HEV ont été testés à l’aide du sérodiagnostic d’agglutination microscopique pour les sérotypes de Leptospira Canicola, Grippotyphosa, Icterohaemorrhagiæ, Bratislava, Pomona et Autumnalis. Dix des 40 chats [25 %; intervalle de confiance (IC) de 95 % : 12,7 % à 41,2 %] ont obtenu des titres d’anticorps positifs (≥ 1:100). Les 10 chats avec des titres positifs étaient positifs pour Bratislava et 2 étaient aussi positifs pour Autumnalis. Cette incidence élevée de séropositivité pour Leptospira peut suggérer que la maladie pourrait être d’une importance clinique supérieure à ce qui était reconnu auparavant.
(Traduit par Isabelle Vallières)
Introduction
Leptospirosis is a zoonotic disease encountered worldwide and is known to affect humans, domestic animals, and wildlife. A re-emergence of the disease in companion animals in the 1990s inspired an increase in the frequency of leptospirosis prevalence studies in dogs (1). Although epidemiologic studies have linked interactions with cats as a risk factor for human leptospirosis, serosurveys of feline Leptospira spp. infection are scarce in the veterinary literature. Recently, serosurveys reported that between 4.8% and 35.3% of cats tested were seropositive for Leptospira spp. in various geographic regions (2–8). Because the prevalence and distribution of this disease vary widely, the presence of Leptospira spp. infection in cats in various geographic areas is questionable and thus often disregarded as a potential cause for disease in cats and as a zoonotic risk (1). Recently, 3 cases of clinical feline leptospirosis were reported from our institution (9). Although leptospirosis has been reported in dogs in Canada, no recent serosurveys in cats are available (10,11). The objective of this study was to determine the seroprevalence of Leptospira spp. antibodies in cats presenting to an eastern Canadian veterinary teaching hospital.
Materials and methods
Between October 1 and December 1, 2007, all feline serum samples obtained from referral cases to the specialty services, the primary care service, or from the emergency and critical care services were submitted to the diagnostic laboratory of the Faculté de Médecine Vétérinaire of the Université de Montréal. Our protocol was approved by the Institutional Animal Care and Use Committee and informed owner consent was obtained.
Blood samples were collected in a dry blood collection tube and serum was immediately separated then submitted daily to the Laboratoire d’Expertise en Pathologie Animale du Québec (LEPAQ) of the Ministry of Agriculture, Fisheries and Food of Quebec (MAPAQ). The samples were stored and antibody titers for the serovars Leptospira interrogans Canicola, Icterohaemorrhagiae, Bratislava, Pomona, Autumnalis, and Leptospira kirschneri serovar Grippotyphosa were measured by microscopic agglutination test (MAT) once weekly. Cats were considered seropositive when they had antibody titers ≥ 1:100. Cats with titers ≥ 1:200 were considered as potential clinical cases and underwent further evaluation with a urinary polymerase chain reaction (PCR) and a convalescent titer to assess if they had active infections (2 to 4 wk following initial serologic testing).
Results
Samples from 40 cats were obtained for analysis. Ten of the 40 cats [25.0%; 95% confidence interval (CI): 12.7% to 41.2%] had positive antibody titers (≥ 1:100). Of the 10 seropositive cats, 6 either had an indoor/outdoor lifestyle or had contacts with other cats. This information was unavailable for 3 cats and 1 cat was an exclusively indoor cat that did not have contact with other cats. Of the 30 seronegative cats, 17 either had an indoor/outdoor lifestyle or had contact with other cats. This information was unavailable for 4 cats and the 9 cats that were kept exclusively indoors did not have any contact with other cats. Three of the 10 seropositive cats had evidence of kidney disease in their blood work, 1 had a recent history of polyuria and polydyspsia, 2 had hepatic lipidosis, 1 was treated for a corneal ulcer, 1 for an anal sac abscess, and 1 was presented to the emergency service because he had been hit by a car. The reason for presentation of 1 cat was unknown. Nine of the 30 seronegative cats had evidence of kidney disease based on their blood work and 4 had some degree of liver disease (1 had hepatic lipidosis, 1 had cholangitis, 2 had increased liver enzymes). The reasons for presentation for the seronegative cats were as follows: 8 cats were referred to specialty services for specific reasons [tachypnea, mammary mass, abdominal mass, diabetes mellitus, suspicion of feline infectious peritonitis, broken canine tooth, investigation of chronic kidney disease (CKD)], 6 cats were presented for non-specific signs (decreased appetite, depression, and vomiting), 6 cats were presented to the internal medicine or ophthalmology services for a follow-up of their known chronic conditions (hyperthyroidism, CKD and uroliths, hyperthyroidism and diabetes mellitus, cholangitis/cholangiohepatitis complex, CKD and chronic eye ulcers, uveitis and chorioretinitis), 5 cats were presented for lower urinary tract signs, 3 cats were presented for neurological investigation (meningitis, inflammatory polyp, vestibular ataxia), 1 cat was presented for dental treatment, and 1 cat was presented for a routine health examination.
Of the seropositive cats, only 1 cat had an initial titer of 1:200 and therefore was a candidate for paired titers and urinary PCR. This 23-year-old Persian cat was euthanized upon presentation, but a postmortem examination was not performed; therefore, its active infection status could not be determined. All 10 cats with positive titers were positive for serovar Bratislava and 2 of the 10 cats were also positive for serovar Autumnalis. None of the cats had received immunization against leptospirosis.
Discussion
The aim of this study was to evaluate the presence of antibodies for Leptospira spp. in cats presenting to an eastern Canadian veterinary teaching hospital. Our study suggests that 1 out of 4 cats from the population of cats seen at our referral hospital carries antibodies against Leptospira spp. This high incidence of seropositivity for Leptospira spp. may suggest that the disease could be of more clinical importance than previously recognized. One study reporting seroprevalence of leptospirosis in cats concluded that 12.8% of the study population had antibody titers ≥ 1:100 (12). In that study, as in ours, the authors considered titers of 1:200 or more to be suspicious for an active infection. Therefore, no cat with an initial titer of 1:100 was evaluated with a convalescent titer, as in our study. It is difficult to assess if cats with clinical leptospirosis tend to have low titers or if they mount a significant immunological response, as is the case in dogs (1). The cats in our study may have been previously exposed to the spirochete without contracting the disease, which would explain the low titers. Following experimental inoculation, the majority (90%) of cats mount high immune response as evidenced by an increase in antibody titer as high as 1:3200 without any clinical or clinicopathologic changes other than a transient mild elevation in body temperature (13). However, as recently reported, cats with clinical leptospirosis can also mount a significant immune response (9). Nevertheless, 3 cats presented with kidney disease and 2 cats with hepatic disease; thus the role of leptospirosis, in cats with low titers but with kidney or liver diseases needs to be further investigated. Moreover, it is possible that lower titers represent cross-reactivity with serovars not tested for, but which are present in the environment. To determine the magnitude of titer elevation in cats with natural active leptospirosis, future studies should consider cats with lower titers as being potentially infected and urinary PCR should be performed upon initial presentation.
An interesting finding from our study is that serovar Bratislava was implicated in all cats that tested positive. The only other serovar identified was Autumnalis, which often increases with the serovar Bratislava in canine leptospirosis. The serovar Autumnalis has not been isolated from dogs in North America (1). However, the serovar Bratislava is recognized as causing clinical disease in dogs in North America. Moreover, antibodies to this serovar were also elevated in 3 of 6 recently reported seropositive cats (5,9). This raises the question as to the source of exposure of cats with this serovar. In fact, cats are suspected of acquiring leptospirosis through contact with rodents, and the serovar Bratislava is naturally carried by mice and rats (6,14,15). Most of the cats from our study could have acquired leptospirosis through contact with rodents or by coming in contact with the other cats within the household. This could explain the high prevalence of this serovar in the cats in our study. However, the proximity of those cats to facilities that house pigs, which are also natural carriers for serovar Bratislava, and recognized as possible sources of infection for leptospirosis in cats, is unknown (15). The implication of contacts with other cats as a risk factor for leptospirosis needs to be further investigated.
Limitations of this study are related to the short length of time for data collection, the limited geographical area, and the small number of cats. Moreover, the lack of information on the carrier status of cats that tested positive prevents further analysis of the role of leptospirosis in their clinical disease.
To the authors’ knowledge, this is the first study in which cats presenting to a referral hospital were systematically screened for leptospirosis, and it is the first seroprevalence study of feline leptospirosis in Quebec. The results of our study suggest that Leptospira spp. infection is present among cats in our hospital population. Its zoonotic risk and potential as an etiologic agent for various diseases should be considered and further investigated. CVJ
Footnotes
Use of this article is limited to a single copy for personal study. Anyone interested in obtaining reprints should contact the CVMA office (hbroughton@cvma-acmv.org) for additional copies or permission to use this material elsewhere.
References
- 1.Sykes JE, Hartmann K, Lunn KF, Moore GE, Stoddard RA, Goldstein RE. 2010 ACVIM small animal consensus statement on leptospirosis: Diagnosis, epidemiology, treatment, and prevention. J Vet Intern Med. 2011;25:1–13. doi: 10.1111/j.1939-1676.2010.0654.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Gamage CD, Yasuda SP, Nishio S, et al. Serological evidence of Thailand virus-related hantavirus infection among suspected leptospirosis patients in Kandy, Sri Lanka. Jpn J Infect Dis. 2011;64:72–75. [PubMed] [Google Scholar]
- 3.Bovet P, Yersin C, Merien F, Davis CE, Perolat P. Factors associated with clinical leptospirosis: A population-based case-control study in the Seychelles (Indian Ocean) Int J Epidemiol. 1999;28:583–590. doi: 10.1093/ije/28.3.583. [DOI] [PubMed] [Google Scholar]
- 4.Leal-Castellanos CB, Garcia-Suárez R, González-Figueroa E, Fuentes-Allen JL, Escobedo-de la Peñal J. Risk factors and the prevalence of leptospirosis infection in a rural community of Chiapas, Mexico. Epidemiol Infect. 2003;131:1149–1156. doi: 10.1017/s0950268803001201. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Markovich JE, Ross L, McCobb E. The prevalence of leptospiral antibodies in free roaming cats in Worcester County, Massachusetts. J Vet Intern Med. 2012;26:688–689. doi: 10.1111/j.1939-1676.2012.00900.x. [DOI] [PubMed] [Google Scholar]
- 6.Agunloye CA, Nash AS. Investigation of possible leptospiral infection in cats in Scotland. J Small Anim Pract. 1996;37:126–129. doi: 10.1111/j.1748-5827.1996.tb02360.x. [DOI] [PubMed] [Google Scholar]
- 7.Millán J, Candela MG, López-Bao JV, Pereira M, Jiménez MA, León-Vizcaino L. Leptospirosis in wild and domestic carnivores in natural areas in Andalusia, Spain. Vector Borne Zoonotic Dis. 2009;9:549–554. doi: 10.1089/vbz.2008.0081. [DOI] [PubMed] [Google Scholar]
- 8.Mylonakis ME, Bourtzi-Hatzopoulou E, Koutinas AF, et al. Leptospiral seroepidemiology in a feline hospital population in Greece. Vet Rec. 2005;156:615–616. doi: 10.1136/vr.156.19.615. [DOI] [PubMed] [Google Scholar]
- 9.Arbour J, Blais MC, Carioto L, Sylvestre D. Clinical leptospirosis in three cats (2001–2009) J Am Anim Hosp Assoc. 2012;48:256–260. doi: 10.5326/JAAHA-MS-5748. [DOI] [PubMed] [Google Scholar]
- 10.Ward MP, Glickman LT, Guptill LE. Prevalence of and risk factors for leptospirosis among dogs in the United States and Canada: 677 cases (1970–1998) J Am Vet Med Assoc. 2002;220:53–58. doi: 10.2460/javma.2002.220.53. [DOI] [PubMed] [Google Scholar]
- 11.Alton GD, Berke O, Reid-Smith R, Ojkic D, Prescott JF. Increase in seroprevalence of canine leptospirosis and its risk factors, Ontario 1998–2006. Can J Vet Res. 2009;73:167–175. [PMC free article] [PubMed] [Google Scholar]
- 12.Larsson CE, Santa Rosa CA, Hagiwara MK, Paim GV, Guerra JL. Prevalence of feline leptospirosis: Serologic survey and attempts of isolation and demonstration of the agent. Int J Zoonoses. 1984;11:161–169. [PubMed] [Google Scholar]
- 13.Larsson CE, Santa Rosa CA, Larsson MH, Birgel EH, Fernandes WR, Paim GV. Laboratory and clinical features of experimental feline leptospirosis. Int J Zoonoses. 1985;12:111–119. [PubMed] [Google Scholar]
- 14.Shophet R. A serological survey of leptospirosis in cats. N Z Vet J. 1979;27:236, 245–246. doi: 10.1080/00480169.1979.34662. [DOI] [PubMed] [Google Scholar]
- 15.Greene CE. Infectious Diseases of the Dog and Cat. 3rd ed. St Louis, Missouri: Saunders Elsevier; 2006. [Google Scholar]